FIPB refers Gland Pharma proposal to CCEA for approval Industry-The Economic Times — April 24, 2017 comments off Gland Pharma Limited is seeking approval for its initial acquisition of up to 86.08 per cent by Shanghai Fosun Pharmaceutical (Group) Company Limited.
Gland Pharma Limited is seeking approval for its initial acquisition of up to 86.08 per cent by Shanghai Fosun Pharmaceutical (Group) Company Limited.